Pyruvate kinase M2 and prednisolone resistance in acute lymphoblastic leukemia

2009-09-01

Haematologica , Volume 94 - Issue 9 p. 1322- 1324

Additional Metadata
Keywords	Childhood ALL, Glycolysis, Perdnisolone, Pyruvate kinase, Resistance, acute lymphoblastic leukemia, bone marrow, drug mechanism, event free survival, glucocorticoid, glucose, glucose metabolism, glycolysis, human, isoenzyme, letter, peripheral lymphocyte, polymerase chain reaction, prednisolone, protein expression, protein phosphorylation, pyruvate kinase, pyruvate kinase m2, treatment failure, unclassified drug, upregulation
Persistent URL	doi.org/10.3324/haematol.2009.011437, hdl.handle.net/1765/17560
Journal	Haematologica
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Hulleman, E., Broekhuis, M., Pieters, R., & den Boer, M. (2009). Pyruvate kinase M2 and prednisolone resistance in acute lymphoblastic leukemia. Haematologica, 94(9), 1322–1324. doi:10.3324/haematol.2009.011437

Publication